[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-346417-105":59,"doc-detail-346417-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","comprehensive-multi-omics-analysis-reveals-runx1s-prognostic-value-immune-associations-and-muc13-mediated-mechanistic-role-in-hepatocellular-carcinoma-pathogenesis","Comprehensive multi-omics analysis reveals RUNX1's prognostic value, immune associations, and MUC13-Mediated mechanistic role in hepatocellular carcinoma pathogenesis","","Hepatocellular carcinoma (HCC) is a biologically and clinically heterogeneous malignancy, creating major obstacles for early diagnosis, prognostic prediction, and therapeutic intervention. Integrative pan-cancer multi-omics analysis across 33 cancer types characterized RUNX family expression, prognostic links, and immune correlations. RUNX1 expression was experimentally validated in HCC and associated with advanced stage, distinct immune subtypes, altered checkpoint profiles, and poorer survival. Mechanistically, MUC13 was identified as a direct transcriptional target of RUNX1, with RUNX1 knockdown suppressing tumor progression via Wnt/β-catenin/EMT signaling attenuation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/comprehensive-multi-omics-analysis-reveals-runx1s-prognostic-value-immune-associations-and-muc13-mediated-mechanistic-role-in-hepatocellular-carcinoma-pathogenesis/346417/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/comprehensive-multi-omics-analysis-reveals-runx1s-prognostic-value-immune-associations-and-muc13-mediated-mechanistic-role-in-hepatocellular-carcinoma-pathogenesis/346417.png","ImageObject",300,407,{"name":92,"@type":93},"Patrick","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-22","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main goal of the study regarding the RUNX family?","Question",{"text":112,"@type":113},"To clarify how the RUNX family contributes to tumor progression and its clinical implications, focusing on expression patterns, prognostic associations, and immune correlations.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the study evaluate RUNX1 prognostic significance in cancer?",{"text":117,"@type":113},"It used Kaplan–Meier survival analysis, Cox regression, and ROC curve evaluation, supported by expression-related assessments in HCC.",{"name":119,"@type":110,"acceptedAnswer":120},"What mechanistic role links RUNX1 to hepatocellular carcinoma progression?",{"text":121,"@type":113},"RUNX1 was shown to transcriptionally target MUC13, and RUNX1 knockdown suppressed HCC proliferation, migration, and invasion by attenuating Wnt/β-catenin/EMT signaling activity.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},346417,1790119733,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},549758146520,"https://ap-avatar.wpscdn.com/avatar/80002397d8c0411e94?_k=1775819394049821470","Biochemistry and Biophysics Reports 45 (2026) 102446  \nContents lists available at ScienceDirect  \nBiochemistry and Biophysics Reports  \njournal [homepage:](homepage: www.elsevier.com/locate/bbrep)[ www.elsevier.com/locate/bbrep](homepage: www.elsevier.com/locate/bbrep)  \n| Comprehensive multi-omics analysis reveals RUNX1's prognostic value, immune associations, and MUC13-Mediated mechanistic role in hepatocellular carcinoma pathogenesis\u003Cbr>Tahani Ahmad ALMatrafi\u003Cbr>Department of Anatomy, College of Medicine, King Saud University, Riyadh, Saudi Arabia |  |  |\n| --- | --- | --- |\n| A R T I C L E I N F O |  | A B S T R A C T |\n| Keywords:\u003Cbr>Hepatocellular carcinoma (HCC) Wnt/β-catenin signaling\u003Cbr>RUNX family Pan-cancer Prognosis Biomarker |  | Hepatocellular carcinoma (HCC) is a biologically and clinically heterogeneous malignancy, posing major challenges for early diagnosis, prognostic prediction, and therapeutic intervention. The Runt-related transcription factor (RUNX) family, comprising RUNX1, RUNX2, and RUNX3, plays essential roles in cellular processes and contribute to the pathogenesis of numerous malignancies. This study aims to elucidate their role in tumor progression and its clinical implications. We performed an integrative pan-cancer multi-omics analysis across 33 cancer types to characterize RUNX family expression patterns, prognostic associations, and immune correlations using publicly available datasets. Expression and functional roles were experimentally validated in HCC through in vitro and in vivo assays. Relationships between RUNX1 expression and clinical stage, immune subtypes, checkpoint gene expression, immunotherapy sensitivity, and immune-related co-expression networks were assessed. The prognostic significance of RUNX1 was determined using Kaplan–Meier survival analysis, Cox regression, and ROC curve evaluation. Transcriptional regulation was investigated via bioinformatic tools, database interrogation, and chromatin immunoprecipitation (ChIP) assays. Functional studies were conducted to determine the effects of RUNX1 knockdown on HCC cell proliferation, migration, and invasion. RUNX1 was upregulated in multiple tumor types, including breast, lung, liver, and brain cancers, and its elevated expression correlated with poorer overall (OS) and disease-specific survival (DSS). In HCC, RUNX1 expression was significantly associated with advanced clinical stage, distinct immune subtypes, and altered checkpoint expression profiles, indicating a role in shaping the tumor immune microenvironment. Mechanistically, MUC13 was identified as a direct transcriptional target of RUNX1, as confirmed by promoter-binding prediction, ChIP validation, and dual-luciferase assays. RUNX1 knockdown suppressed HCC cell proliferation, migration, and invasion by attenuating Wnt/β-catenin/EMT signaling activity. These findings highlight RUNX1 as a potential prognostic biomarker and therapeutic target, offering mechanistic insight into HCC pathogenesis and avenues for improved precision oncology. |\n\n1. Introduction  \nCancer remains one of the most formidable global health challenges, with an estimated 19.3 million new cases diagnosed annually across more than 30 cancer types. According to Global Cancer Statistics 2020, malignancies account for approximately 10 million deaths each year, underscoring the urgent need for improved diagnostic, prognostic, and therapeutic strategies [1]. Late-stage detection is a major determinant of cancer mortality, emphasizing the pivotal importance of early screening, molecular profiling, and precise diagnosis to enhance survival outcomes [2]. Tumorigenesis arises from complex interactions among genetic,  \nepigenetic, and environmental factors that collectively disrupt cellular homeostasis [3–8]. These alterations reshape the tumor microenvironment (TME), a dynamic ecosystem comprising malignant cells, immune infiltrates, fibroblasts, endothelial cells, and an extracellular matrix undergoing constant ","cbCaidQavS4EDwTL","https://ap.wps.com/l/cbCaidQavS4EDwTL","pdf",13619455,15,"English","# Introduction\n## Tumor heterogeneity and the tumor microenvironment\n## Multi-omics advances and RUNX family in cancer","[{\"question\":\"What was the main goal of the study regarding the RUNX family?\",\"answer\":\"To clarify how the RUNX family contributes to tumor progression and its clinical implications, focusing on expression patterns, prognostic associations, and immune correlations.\"},{\"question\":\"How did the study evaluate RUNX1 prognostic significance in cancer?\",\"answer\":\"It used Kaplan–Meier survival analysis, Cox regression, and ROC curve evaluation, supported by expression-related assessments in HCC.\"},{\"question\":\"What mechanistic role links RUNX1 to hepatocellular carcinoma progression?\",\"answer\":\"RUNX1 was shown to transcriptionally target MUC13, and RUNX1 knockdown suppressed HCC proliferation, migration, and invasion by attenuating Wnt/β-catenin/EMT signaling activity.\"}]","Comprehensive multi-omics analysis reveals RUNX1's prognostic value, immune associations, and MUC13-Mediated mechanistic role in hepatocellular carcinoma pathogenesis | PDF",1790061359,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8fd2c56ff1bbc5a5bf1492bb7d62490d.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ed7678f1194ccf04f2fce0ccb212b59c.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b670229e2d4a9373f4f71199265e69f4.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3f5adf69c5b05ff9c9e6a70198ea8a93.webp",980,1306]